Results 51 to 60 of about 487,201 (201)

der(6)t(1;6)(q21;p21) in myelofibrosis following polycythemia vera [PDF]

open access: yes, 2011
Case report of a translocation : der(6)t(1;6)(q21;p21) in myelofibrosis following polycythemia ...
Zamecnikova, A, A Zamecnikova
core   +1 more source

The utility of testing erythropoietin level in polycythemia diagnosis

open access: yesHematology, 2023
Objectives: Polycythemia vera (PV) is classically thought to be associated with low erythropoietin (EPO) levels. Here, we present a review of the utility of using EPO levels in diagnosing polycythemia.Methods: We conducted a systematic literature review ...
Abdellatif Ismail   +7 more
doaj   +1 more source

Familial polycythemia vera

open access: yesCleveland Clinic Journal of Medicine, 1989
The occurrence of polycythemia vera in a father, mother, and two sons is reported. Thirteen kindreds with familial polycythemia vera in 31 members are reviewed. Comprehensive records were available for all four patients as well as other family members, since all were diagnosed and treated at the author's institution over a period of nearly 50 years ...
R L, Miller, J D, Purvis, J K, Weick
openaire   +2 more sources

The Impact of Current Treatment on The Symptomatology and Complications of Patients with Polycythemia Vera [PDF]

open access: yesDocumenta Haematologica
Introduction: polycythemia vera is a Ph-negative relatively indolent chronic myeloproliferative disease, with a high risk of arterial and venous thrombosis, affecting patient survival.
Marc-Tudor DAMIAN   +2 more
doaj   +1 more source

Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia

open access: yes, 2002
To examine the utility of polycythemia rubra vera-1 (PRV-1)-specific reverse transcriptase polymerase chain reaction (RT-PCR) to discriminate essential thrombocythemia (ET) and polycythemia vera (PV) from secondary thrombocytosis (ST) or secondary ...
Teofili, Luciana   +13 more
core   +1 more source

Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry

open access: yesHematology, Transfusion and Cell Therapy
Introduction: Philadelphia-negative myeloproliferative neoplasms are clonal blood disorders characterized by abnormal blood cell production. This study explores the clinical and epidemiological profiles of 111 Ecuadorian patients diagnosed with ...
C Freire   +8 more
doaj   +1 more source

Management of hydroxyurea resistant or intolerant polycythemia vera [PDF]

open access: yes, 2021
Polycythemia vera is a Philadelphia negative myeloproliferative neoplasm characterized by erythrocytosis in which the major cause of morbidity and mortality is thrombosis.
Yannakou, CK   +3 more
core   +1 more source

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET

open access: yes, 2023
Wille K, Brouka M, Bernhardt J, et al. Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET. HemaSphere.
Frank Stegelmann   +39 more
core   +1 more source

Polycythemia vera: gender-related phenotypic differences

open access: yes, 2011
In polycythemia vera, gender has recently been shown to influence the JAK2(V617F) allele burden, but its effect on the disease phenotype is unknown.
RosaMaria Marfisi   +9 more
core   +1 more source

POLYCYTHEMIA VERA: PRESENTATION AND MANAGEMENT

open access: yes, 2019
: Background: Polycythemia vera (PV), alongside primary myelofibrosis (MF) and essential thrombocythemia (ET), is a classic Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) characterized primarily by an expanded red platelet mass ...
Omar Hasan Badahman, Hassan Abdulwahab Almumen, Ali Abdulaziz Alshamrani, Esraa Ebraheem Kamal, Alaa Jamal Akbar, Shaima Mohammed Alghuraybi, Eidan Bakheet Almalki, Abdulsalam Jawwad Al Hassan, Zainab Hassan Albahrani, Asmaa Abdullah Alzahrani
core   +1 more source

Home - About - Disclaimer - Privacy